# AppLovin Corp: financial statements, quarterly APP · Nasdaq · CIK 1751008 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/app.md) · [Financials](/companies/app/financials.md) · [Filings](/companies/app/filings.md) · [Insiders](/companies/app/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/app/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [864](/filings/0001751008-24-000062.md) | [(488) d](/filings/0001751008-26-000010.md) | [1,058](/filings/0001751008-25-000053.md) | [711](/filings/0001751008-25-000072.md) | [835](/filings/0001751008-25-000081.md) | [999 d](/filings/0001751008-26-000010.md) | [1,159](/filings/0001751008-26-000044.md) | [1,259](/filings/0001751008-26-000059.md) | [1,405](/filings/0001751008-25-000081.md) | [1,658 d](/filings/0001751008-26-000010.md) | [1,842](/filings/0001751008-26-000044.md) | [1,924](/filings/0001751008-26-000059.md) | | Cost of revenue | $m | [265](/filings/0001751008-24-000062.md) | [(429) d](/filings/0001751008-26-000010.md) | [294](/filings/0001751008-25-000053.md) | [122](/filings/0001751008-25-000072.md) | [121](/filings/0001751008-25-000081.md) | [153 d](/filings/0001751008-26-000010.md) | [152](/filings/0001751008-26-000044.md) | [155](/filings/0001751008-26-000059.md) | [175](/filings/0001751008-25-000081.md) | [184 d](/filings/0001751008-26-000010.md) | [204](/filings/0001751008-26-000044.md) | [226](/filings/0001751008-26-000059.md) | | Research and development | $m | [159](/filings/0001751008-24-000062.md) | [(108) d](/filings/0001751008-26-000010.md) | [155](/filings/0001751008-25-000053.md) | [99.1](/filings/0001751008-25-000072.md) | [80.8](/filings/0001751008-25-000081.md) | [106 d](/filings/0001751008-26-000010.md) | [56.4](/filings/0001751008-26-000044.md) | [44.0](/filings/0001751008-26-000059.md) | [43.9](/filings/0001751008-25-000081.md) | [82.2 d](/filings/0001751008-26-000010.md) | [94.1](/filings/0001751008-26-000044.md) | [99.9](/filings/0001751008-26-000059.md) | | Operating income | $m | [186](/filings/0001751008-24-000062.md) | [394 d](/filings/0001751008-26-000010.md) | [340](/filings/0001751008-25-000053.md) | [384](/filings/0001751008-25-000072.md) | [534](/filings/0001751008-25-000081.md) | [628 d](/filings/0001751008-26-000010.md) | [840](/filings/0001751008-26-000044.md) | [958](/filings/0001751008-26-000059.md) | [1,079](/filings/0001751008-25-000081.md) | [1,275 d](/filings/0001751008-26-000010.md) | [1,440](/filings/0001751008-26-000044.md) | [1,494](/filings/0001751008-26-000059.md) | | Interest expense | $m | [78.6](/filings/0001751008-24-000062.md) | not reported | [74.2](/filings/0001751008-25-000053.md) | [74.4](/filings/0001751008-25-000072.md) | [74.9](/filings/0001751008-25-000081.md) | not reported | [52.9](/filings/0001751008-26-000044.md) | [51.4](/filings/0001751008-26-000059.md) | [51.4](/filings/0001751008-25-000081.md) | not reported | [51.2](/filings/0001751008-26-000044.md) | [51.2](/filings/0001751008-26-000059.md) | | Income tax | $m | [0.6](/filings/0001751008-24-000062.md) | [26.6 d](/filings/0001751008-26-000010.md) | [31.8](/filings/0001751008-25-000053.md) | [16.9](/filings/0001751008-25-000072.md) | [34.7](/filings/0001751008-25-000081.md) | [(61.4) d](/filings/0001751008-26-000010.md) | [71.1](/filings/0001751008-26-000044.md) | [112](/filings/0001751008-26-000059.md) | [185](/filings/0001751008-25-000081.md) | [151 d](/filings/0001751008-26-000010.md) | [226](/filings/0001751008-26-000044.md) | [239](/filings/0001751008-26-000059.md) | | Net income | $m | [109](/filings/0001751008-24-000062.md) | [172 d](/filings/0001751008-26-000010.md) | [236](/filings/0001751008-25-000081.md) | [310](/filings/0001751008-25-000081.md) | [434](/filings/0001751008-25-000081.md) | [599 d](/filings/0001751008-26-000010.md) | [576](/filings/0001751008-26-000059.md) | [820](/filings/0001751008-26-000059.md) | [836](/filings/0001751008-25-000081.md) | [1,102 d](/filings/0001751008-26-000010.md) | [1,206](/filings/0001751008-26-000059.md) | [1,267](/filings/0001751008-26-000059.md) | | Diluted EPS | $ per share | [0.30](/filings/0001751008-24-000062.md) | not reported | [0.67](/filings/0001751008-25-000053.md) | [0.89](/filings/0001751008-25-000072.md) | [1.25](/filings/0001751008-25-000081.md) | not reported | [1.67](/filings/0001751008-26-000044.md) | [2.39](/filings/0001751008-26-000059.md) | [2.45](/filings/0001751008-25-000081.md) | not reported | [3.56](/filings/0001751008-26-000044.md) | [3.76](/filings/0001751008-26-000059.md) | | Basic EPS | $ per share | [0.32](/filings/0001751008-24-000062.md) | not reported | [0.70](/filings/0001751008-25-000053.md) | [0.92](/filings/0001751008-25-000072.md) | [1.29](/filings/0001751008-25-000081.md) | not reported | [1.70](/filings/0001751008-26-000044.md) | [2.42](/filings/0001751008-26-000059.md) | [2.47](/filings/0001751008-25-000081.md) | not reported | [3.57](/filings/0001751008-26-000044.md) | [3.77](/filings/0001751008-26-000059.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [332](/filings/0001751008-23-000072.md) | [502](/filings/0001751008-25-000018.md) | [436](/filings/0001751008-24-000043.md) | [460](/filings/0001751008-24-000055.md) | [568](/filings/0001751008-24-000062.md) | [697](/filings/0001751008-26-000010.md) | [551](/filings/0001751008-25-000053.md) | [1,193](/filings/0001751008-25-000072.md) | [1,667](/filings/0001751008-25-000081.md) | [2,487](/filings/0001751008-26-000059.md) | [2,759](/filings/0001751008-26-000044.md) | [3,053](/filings/0001751008-26-000059.md) | | Current assets | $m | [1,301](/filings/0001751008-23-000072.md) | [1,616](/filings/0001751008-25-000018.md) | [1,608](/filings/0001751008-24-000043.md) | [1,660](/filings/0001751008-24-000055.md) | [1,875](/filings/0001751008-24-000062.md) | [2,312](/filings/0001751008-26-000010.md) | [2,367](/filings/0001751008-25-000053.md) | [2,993](/filings/0001751008-25-000072.md) | [3,488](/filings/0001751008-25-000081.md) | [4,431](/filings/0001751008-26-000059.md) | [4,848](/filings/0001751008-26-000044.md) | [5,392](/filings/0001751008-26-000059.md) | | Total assets | $m | [5,005](/filings/0001751008-23-000072.md) | [5,359](/filings/0001751008-25-000018.md) | [5,263](/filings/0001751008-24-000043.md) | [5,269](/filings/0001751008-24-000055.md) | [5,442](/filings/0001751008-24-000062.md) | [5,869](/filings/0001751008-26-000010.md) | [5,707](/filings/0001751008-25-000053.md) | [5,959](/filings/0001751008-25-000072.md) | [6,343](/filings/0001751008-25-000081.md) | [7,260](/filings/0001751008-26-000059.md) | [7,708](/filings/0001751008-26-000044.md) | [8,269](/filings/0001751008-26-000059.md) | | Current liabilities | $m | [805](/filings/0001751008-23-000072.md) | [944](/filings/0001751008-25-000018.md) | [763](/filings/0001751008-24-000043.md) | [730](/filings/0001751008-24-000055.md) | [780](/filings/0001751008-24-000062.md) | [1,057](/filings/0001751008-26-000010.md) | [1,409](/filings/0001751008-25-000053.md) | [1,094](/filings/0001751008-25-000072.md) | [1,073](/filings/0001751008-25-000081.md) | [1,334](/filings/0001751008-26-000059.md) | [1,494](/filings/0001751008-26-000044.md) | [1,254](/filings/0001751008-26-000059.md) | | Total liabilities | $m | [3,909](/filings/0001751008-23-000072.md) | [4,103](/filings/0001751008-25-000018.md) | [4,502](/filings/0001751008-24-000043.md) | [4,455](/filings/0001751008-24-000055.md) | [4,504](/filings/0001751008-24-000062.md) | [4,779](/filings/0001751008-26-000010.md) | [5,131](/filings/0001751008-25-000053.md) | [4,792](/filings/0001751008-25-000072.md) | [4,869](/filings/0001751008-25-000081.md) | [5,125](/filings/0001751008-26-000059.md) | [5,344](/filings/0001751008-26-000044.md) | [5,106](/filings/0001751008-26-000059.md) | | Long-term debt | $m | [2,912](/filings/0001751008-23-000072.md) | [2,906](/filings/0001751008-25-000018.md) | [3,490](/filings/0001751008-24-000043.md) | [3,482](/filings/0001751008-24-000055.md) | [3,474](/filings/0001751008-24-000062.md) | [3,509](/filings/0001751008-26-000010.md) | [3,510](/filings/0001751008-25-000053.md) | [3,511](/filings/0001751008-25-000072.md) | [3,512](/filings/0001751008-25-000081.md) | [3,513](/filings/0001751008-26-000059.md) | [3,514](/filings/0001751008-26-000044.md) | [3,515](/filings/0001751008-26-000059.md) | | Current portion of debt | $m | not reported | [215](/filings/0001751008-25-000018.md) | not reported | not reported | not reported | [0.0](/filings/0001751008-25-000018.md) | not reported | not reported | not reported | not reported | not reported | not reported | | Short-term borrowings | $m | [215](/filings/0001751008-23-000072.md) | [215](/filings/0001751008-25-000018.md) | [35.6](/filings/0001751008-24-000043.md) | [35.6](/filings/0001751008-24-000055.md) | [35.6](/filings/0001751008-24-000062.md) | [0.0](/filings/0001751008-25-000053.md) | [200](/filings/0001751008-25-000053.md) | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [1,096](/filings/0001751008-24-000062.md) | [1,256](/filings/0001751008-26-000010.md) | [760](/filings/0001751008-25-000081.md) | [815](/filings/0001751008-25-000081.md) | [938](/filings/0001751008-25-000081.md) | [1,090](/filings/0001751008-26-000059.md) | [575](/filings/0001751008-26-000059.md) | [1,167](/filings/0001751008-26-000059.md) | [1,474](/filings/0001751008-25-000081.md) | [2,135](/filings/0001751008-26-000059.md) | [2,363](/filings/0001751008-26-000059.md) | [3,163](/filings/0001751008-26-000059.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Short-term borrowings: us-gaap:ShortTermBorrowings - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [199 d](/filings/0001751008-24-000062.md) | [344 d](/filings/0001751008-26-000010.md) | [393](/filings/0001751008-25-000053.md) | [455 d](/filings/0001751008-25-000072.md) | [551 d](/filings/0001751008-25-000081.md) | [701 d](/filings/0001751008-26-000010.md) | [832](/filings/0001751008-26-000044.md) | [772 d](/filings/0001751008-26-000059.md) | [1,053 d](/filings/0001751008-25-000081.md) | [1,314 d](/filings/0001751008-26-000010.md) | [1,291](/filings/0001751008-26-000044.md) | [869 d](/filings/0001751008-26-000059.md) | | Capital expenditure | $m | [0.2 d](/filings/0001751008-23-000072.md) | [0.2 d](/filings/0001751008-25-000018.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Share repurchases | $m | [581 d](/filings/0001751008-24-000062.md) | [0.0 d](/filings/0001751008-26-000010.md) | [752](/filings/0001751008-25-000053.md) | [0.0 d](/filings/0001751008-25-000072.md) | [228 d](/filings/0001751008-25-000081.md) | [0.6 d](/filings/0001751008-26-000010.md) | [1,001](/filings/0001751008-26-000044.md) | [272 d](/filings/0001751008-26-000059.md) | [502 d](/filings/0001751008-25-000081.md) | [418 d](/filings/0001751008-26-000010.md) | [982](/filings/0001751008-26-000044.md) | [551 d](/filings/0001751008-26-000059.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [378](/filings/0001751008-23-000072.md) | [373](/filings/0001751008-24-000043.md) | [366](/filings/0001751008-24-000055.md) | [357](/filings/0001751008-24-000062.md) | [349](/filings/0001751008-25-000053.md) | [348](/filings/0001751008-25-000072.md) | [348](/filings/0001751008-25-000081.md) | [345](/filings/0001751008-26-000044.md) | [342](/filings/0001751008-26-000059.md) | [341](/filings/0001751008-25-000081.md) | [339](/filings/0001751008-26-000044.md) | [337](/filings/0001751008-26-000059.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.